Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 45 Records) |
Query Trace: Ovarian Neoplasms and RAD51[original query] |
---|
RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral oncology 2013 Dec . Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, Schäfer KL, Wagenmann M, Schipper J, Hanenberg H |
Germline mutation in the RAD51B gene confers predisposition to breast cancer. BMC cancer 2013 13 (1): 484. Golmard Lisa, Caux-Moncoutier Virginie, Davy Grégoire, Al Ageeli Essam, Poirot Brigitte, Tirapo Carole, Michaux Dorothée, Barbaroux Catherine, d'Enghien Catherine Dubois, Nicolas André, Castéra Laurent, Sastre-Garau Xavier, Stern Marc-Henri, Houdayer Claude, Stoppa-Lyonnet Dominiq |
RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Familial cancer 2014 Jun 13 (2): 173-80. Krivokuca Ana M, Malisic Emina J, Dobricic Jelena D, Brotto Ksenija V, Cavic Milena R, Jankovic Radmila N, Tomasevic Zorica I, Brankovic-Magic Mirjana |
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC medical genetics 2014 15 (1): 55. Silva Felipe C, Lisboa Bianca Cg, Figueiredo Marcia Cp, Torrezan Giovana T, Santos Erika Mm, Krepischi Ana C, Rossi Benedito M, Achatz Maria I, Carraro Dirce |
Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls. Familial cancer 2014 Dec 13 (4): 515-26. Zhang Bei-Bei, Wang Dao-Gang, Xuan Chao, Sun Gui-Li, Deng Kai-Fe |
The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5797-804. Shi Shujing, Qin Lingyan, Tian Mengqiu, Xie Mao, Li Xiaoxue, Qi Chenglin, Yi Xia |
A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study. BMC cancer 2014 14 850. Brandalize Ana Paula Carneiro, Schüler-Faccini Lavínia, Hoffmann Jean-Sébastien, Caleffi Maira, Cazaux Christophe, Ashton-Prolla Patric |
RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis. Diagnostic pathology 2014 9 (1): 18. Cheng Dan, Shi Huimin, Zhang Kan, Yi Lingling, Zhen Guoh |
Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer. Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Dec 64 (4): 290-5. Smolarz B, Makowska M, Samulak D, Michalska M M, Mojs E, Romanowicz H, Wilczak |
Screening of HELQ in breast and ovarian cancer families. Familial cancer 2015 Sep . Pelttari Liisa M, Kinnunen Laura, Kiiski Johanna I, Khan Sofia, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families. SpringerPlus 2015 4 92. Pelttari Liisa M, Kiiski Johanna I, Ranta Salla, Vilske Sara, Blomqvist Carl, Aittomäki Kristiina, Nevanlinna He |
Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation. Familial cancer 2015 Sep 14 (3): 341-8. Vietri Maria Teresa, Caliendo Gemma, Schiano Concetta, Casamassimi Amelia, Molinari Anna Maria, Napoli Claudio, Cioffi Miche |
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget 2016 Jan . French Juliet D, Johnatty Sharon E, Lu Yi, Beesley Jonathan, Gao Bo, Kalimutho Murugan, Henderson Michelle J, Russell Amanda J, Kar Siddhartha, Chen Xiaoqing, Hillman Kristine M, Kaufmann Susanne, Sivakumaran Haran, O'Reilly Martin, Wang Chen, Korbie Darren J, Study Group Australian Ovarian Cancer, Study Australian Cancer, Lambrechts Diether, Despierre Evelyn, Nieuwenhuysen Els Van, Lambrechts Sandrina, Vergote Ignace, Karlan Beth, Lester Jenny, Orsulic Sandra, Walsh Christine, Fasching Peter A, Beckmann Matthias W, Ekici Arif B, Hein Alexander, Matsuo Keitaro, Hosono Satoyo, Pisterer Jacobus, Hillemanns Peter, Nakanishi Toru, Yatabe Yasushi, Goodman Marc T, Lurie Galina, Matsuno Rayna K, Thompson Pamela J, Pejovic Tanja, Bean Yukie, Heitz Florian, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Estrid, Kjaer Susanne K, Jensen Allan, Hogdall Claus, Lundvall Lene, Engelholm Svend Aage, Brown Bob, Flanagan James M, Metcalf Michelle D, Siddiqui Nadeem, Sellers Thomas, Fridley Brooke, Cunningham Julie, Schildkraut Joellen M, Iversen Ed, Weber Rachel Palmieri, Brennan Donal, Berchuck Andrew, Pharoah Paul, Harnett Paul, Norris Murray D, Haber Michelle, Goode Ellen L, Lee Jason S, Khanna Kum Kum, Meyer Kerstin B, Chenevix-Trench Georgia, deFazio Anna, Edwards Stacey L, MacGregor Stuart, Association Consortium On Behalf Of The Ovarian Canc |
RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a meta-analysis. International journal of clinical and experimental medicine 2015 8 (12): 22365-70. Hu Xingzhong, Sun Su |
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers. European journal of human genetics : EJHG 2017 Dec 25 (12): 1345-1353. Golmard Lisa, Castéra Laurent, Krieger Sophie, Moncoutier Virginie, Abidallah Khadija, Tenreiro Henrique, Laugé Anthony, Tarabeux Julien, Millot Gael A, Nicolas André, Laé Marick, Abadie Caroline, Berthet Pascaline, Polycarpe Florence, Frébourg Thierry, Elan Camille, de Pauw Antoine, Gauthier-Villars Marion, Buecher Bruno, Stern Marc-Henri, Stoppa-Lyonnet Dominique, Vaur Dominique, Houdayer Clau |
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 11 24 (2): 326-333. Labidi-Galy S Intidhar, Olivier Timothée, Rodrigues Manuel, Ferraioli Domenico, Derbel Olfa, Bodmer Alexandre, Petignat Patrick, Rak Beata, Chopin Nicolas, Tredan Olivier, Heudel Pierre-Etienne, Stuckelberger Sarah, Meeus Pierre, Meraldi Patrick, Viassolo Valeria, Ayme Aurélie, Chappuis Pierre O, Stern Marc-Henri, Houdayer Claude, Stoppa-Lyonnet Dominique, Buisson Adrien, Golmard Lisa, Bonadona Valérie, Ray-Coquard Isabel |
Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis. Medicine 2018 Jun 97 (26): e11251. Zeng Xianling, Zhang Yafei, Yang Lei, Xu Huiqiu, Zhang Taohong, An Ruifang, Zhu Kex |
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer. Gynecologic oncology 2018 03 148 (3): 553-558. Kessous Roy, Octeau David, Klein Kathleen, Tonin Patricia N, Greenwood Celia M T, Pelmus Manuela, Laskov Ido, Kogan Liron, Salvador Shannon, Lau Susie, Yasmeen Amber, Gotlieb Walter |
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development. Frontiers in genetics 2018 10 9 397. Maresca Luisa, Lodovichi Samuele, Lorenzoni Alessandra, Cervelli Tiziana, Monaco Rossella, Spugnesi Laura, Tancredi Mariella, Falaschi Elisabetta, Zavaglia Katia, Landucci Elisabetta, Roncella Manuela, Congregati Caterina, Gadducci Angiolo, Naccarato Antonio Giuseppe, Caligo Maria Adelaide, Galli Alva |
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer. Pathology oncology research : POR 2019 Feb . Smolarz Beata, Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Wójcik Lui |
Investigation into the origins of an ancient BRCA1 founder mutation identified among Chinese families in Singapore. International journal of cancer 2020 Aug . Shaw Tarryn, Chan Sock Hoai, Teo Jing Xian, Chong Siao Ting, Li Shao-Tzu, Courtney Eliza, Ishak Diana, Sankar Haresh, Ang Zoe Li Ting, Chiang Jianbang, Loh Marie, Zhou Li, Lee Soo Chin, Yeh Hui-Yuan, Kolinjivadi Arun Mouli, Lim Weng Khong, Ngeow Joan |
Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC medical genomics 2020 Feb 13 (1): 21. da Costa E Silva Carvalho Simone, Cury Nathalia Moreno, Brotto Danielle Barbosa, de Araujo Luiza Ferreira, Rosa Reginaldo Cruz Alves, Texeira Lorena Alves, Plaça Jessica Rodrigues, Marques Adriana Aparecida, Peronni Kamila Chagas, Ruy Patricia de Cássia, Molfetta Greice Andreotti, Moriguti Julio Cesar, Carraro Dirce Maria, Palmero Edenir Inêz, Ashton-Prolla Patricia, de Faria Ferraz Victor Evangelista, Silva Wilson Arau |
Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition. Genes, chromosomes & cancer 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Molnar Ioana, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer. Experimental cell research 2021 Jul 406 (1): 112742. Zhang Guonan, Zhang Jie, Zhu Yi, Liu Hong, Shi Yu, Mi Kun, Li Meiying, Zhao Qi, Huang Ziyi, Huang Jianmi |
Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study. Molecular biology reports 2021 Jun . Gowtham Kumar G, Paul Solomon Franklin Durairaj, Martin Jovita, Manickavasagam M, Sundersingh Shirley, Ganesan Nalini, Ramya R, Usha Rani G, Andrea Mary Franc |
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. NPJ breast cancer 2021 Oct 7 (1): 135. Setton Jeremy, Selenica Pier, Mukherjee Semanti, Shah Rachna, Pecorari Isabella, McMillan Biko, Pei Isaac X, Kemel Yelena, Ceyhan-Birsoy Ozge, Sheehan Margaret, Tkachuk Kaitlyn, Brown David N, Zhang Liying, Cadoo Karen, Powell Simon, Weigelt Britta, Robson Mark, Riaz Nadeem, Offit Kenneth, Reis-Filho Jorge S, Mandelker Dia |
Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. NPJ breast cancer 2022 7 8 (1): 86. Wu Shijie, Qi Lina, Chen Huihui, Zhang Kun, He Jiapan, Guo Xianan, Shen Lu, Zhou Yunxiang, Zhong Xi, Zheng Shu, Zhou Jiaojiao, Chen Yidi |
Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2022 2 42 (1): 89-92. Gregory-Davis Kalin J, Walker Allison, Colello Laura S, McKinnon Wendy, Everett Elise, Chang Martin |
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. Annals of oncology : official journal of the European Society for Medical Oncology 2022 12 34 (2): 152-162. Labidi-Galy S I, Rodrigues M, Sandoval J L, Kurtz J E, Heitz F, Mosconi A M, Romero I, Denison U, Nagao S, Vergote I, Parma G, Nøttrup T J, Rouleau E, Garnier G, El-Balat A, Zamagni C, Martín-Lorente C, Pujade-Lauraine E, Fiévet A, Ray-Coquard I |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: